Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan…
Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead manufacturing process…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
remdesivir
Gilead scouting for partners in India, Pak for remdesivir
Recent clinical trial results and the decision by the US Food and Drug Administration (FDA) to issue ''Emergency Use…
Gilead’s anti-viral remdesivir may be found effective against coronavirus
The company is in discussions with some of the world’s leading chemical and pharmaceutical manufacturing companies about their…
US emergency approval broadens use of Gilead’s COVID-19 drug remdesivir
Gilead said that the drug, which is given by intravenous infusion, had helped improve outcomes for patients with COVID-19, the…
US FDA issues EUA for remdesivir for COVID-19 treatment
The EUA allows for remdesivir to be distributed in the US and administered intravenously by healthcare providers, as appropriate,…
Trial of Gilead’s potential coronavirus treatment running ahead of schedule – researcher
Preliminary findings from the randomized trial of the antiviral drug remdesivir, begun in February by the National Institute of…
IICT, LAXAI LifeSciences collaborate for key pharma intermediates
The collaboration will primarily focus on umifenovir, remdesivir and a key intermediate of hydroxychloroquine
Gilead disputes report that its drug flopped in leaked coronavirus trial
In the Chinese trial remdesivir, given by intravenous infusion, failed to improve patients’ condition or reduce the pathogen’s…
Report says COVID-19 patients respond to Gilead’s remdesivir
A medical news website reported that UChicago Medicine recruited 113 people with severe COVID-19 into Gilead’s trial. It said most…
A dive into COVID-19 treatment avenues
"Frost & Sullivan’s analysis reveals that hydroxychloroquine and Remdesivir are likely to emerge as important treatment…